Legend Biotech Corp (LEGN)
32.80
-1.13
(-3.33%)
USD |
NASDAQ |
Dec 24, 16:00
Legend Biotech Total Liabilities (Quarterly): 619.72M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Johnson & Johnson | 108.13B |
| Gilead Sciences Inc | 36.14B |
| Ligand Pharmaceuticals Inc | 113.69M |
| Arcellx Inc | 281.89M |
| CEL-SCI Corp | 15.60M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.736B |
| Shareholders Equity (Quarterly) | 1.116B |
| Debt to Equity Ratio | 0.2658 |
| Current Ratio | 4.984 |
| Net Debt Paydown Yield | -0.06% |